A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Ibandronate


Let's Make May the Month to Tame Osteoporosis Hype  -  May 23, 2007
Women's eNews,These include the bisphosphonates known as alendronate (brand name Fosamax), risedronate (Actonel) and ibandronate (Boniva); the hormone calcitonin

Osteoporosis Treatment -- Without Estrogen  -  May 13, 2007
Medical News Today (press release),Bisphosphonates available to treat osteoporosis include alendronate (Fosamax), ibandronate (Boniva) and risedronate (Actonel).

Once-yearly medication shown to significantly reduce bone ...  -  May 2, 2007
CNW Telbec (Communiqués de presse),Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal women. J Bone Miner Res 2004;19:1241-9.

Dr. Bill Elliott: Lifestyle changes can help prevent bone loss  -  May 21, 2007
Marin Independent-Journal,Bisphosphonate medications such as alendronate (Fosamax), risedronate (Actonel) and ibandronate (Boniva) are first-line treatment.

The Ultimate in Drug Adherence  -  May 16, 2007
HealthandAge.comRecently, a once-a-month tablet has become available - ibandronate, or Boniva®. Now we have the ultimate in aid to adherence - a once a year intravenous

Piribo: New Report on the Women's Health Pharmaceutical Market to 2011  -  May 11, 2007
PR Web (press release),GSK's Boniva (ibandronate) indicated for the treatment of osteoporosis is forecast to accrue $1309m by the end of the forecast period in 2011.

Discover which Indications have the Greatest Potential to Provide ...  -  Apr 30, 2007
PharmaLive.com (press release),Of the newly launched products that are considered to be associated with strong potential success, GSK's Boniva (ibandronate) indicated for the treatment of

Focus on the Women's Health Market to 2011  -  26 Apr 2007
PharmaLive.com (press release),Of the newly launched products that are considered to be associated with strong potential success, GSK's Boniva (ibandronate) indicated for the treatment of

IV Ibandronate Injections Show Favourable Renal Tolerability in ...  -  Apr 16, 2007
DG NewsSEATTLE, WA -- April 16, 2007 -- The effect of IV ibandronate injections in postmenopausal women with normal renal function or mild to moderate renal

FDA approves new Actonel dose  -  Apr 19, 2007
News-Medical.net,With Actonel, patients can get their morning coffee up to 30 minutes sooner than with ibandronate 150 mg tablets, taken once monthly, which requires a wait

Skye formulation accepted for GSK drug  -  Apr 16, 2007
In-PharmaTechnologist.com,GSK highlights Requip as one of its 'rising stars' for 2007 sales (along with Avodart (Dutasteride) and Boniva/Bonviva (ibandronate)), though has cautioned

Bisphosphonate-associated necrosis of the jaws  -  Mar 28, 2007
Woman Dentist Journal,Commonly used oral bisphosphonates include tiludronate (Skelid), alendronate (Fosamax), risedronate (Actonel), etidronate (Didronel), and ibandronate

Vitamin D may prevent alcohol-related bone loss  -  Jan 30, 2007
Stuff.co.nz,New research conducted in rats now suggests that vitamin D or the anti-osteoporosis drug Boniva (ibandronate) can prevent alcohol-related bone loss caused

Update in Osteoporosis  -  18 Jan 2007
Medscape (subscription)The newer nitrogen-containing bisphosphonates, including alendronate, risedronate, pamidronate, zoledronate, and now ibandronate, have increased the options

Vitamin D Or Boniva® (ibandronate) Reduces Bone Loss From Binge ...  -  Jan 1, 2007
Medical News Today (press release),Roche provided the ibandronate. For more information on Loyola University Health System, log onto http://www.loyolamedicine.org.

Vitamin D or Boniva® (ibandronate) Reduces Bone Loss from Binge ...  -  Dec 26, 2006
Newswise (press release)Roche provided the ibandronate. Loyola University Health System, a wholly owned subsidiary of Loyola University Chicago (LUC), includes the private teaching

Nancy Whelan: Osteoporosis medications can have side effects  -  Jan 5, 2007
Sebastian Sun (subscription),Bisphosphonate drugs (alendronate, ibandronate, risedronate, calcitonin, estrogens and raloxifene) work by affecting the bone remodeling cycle.

Alendronate Improves Screw Fixation in Osteoporotic Bone  -  Jan 2, 2007
Journal of Bone and Joint Surgery (subscription)In a murine study, the local delivery of ibandronate resulted in a substantial increase of 60% in the removal torque of stainless-steel screws two weeks

Oral Ibandronate Offers Palliative Befits to Patients Who Progress ...  -  Dec 19, 2006
DG NewsSAN ANTONIO, TX -- December 19, 2006 -- Second-line therapy with oral ibandronate can provide significant palliative benefits to patients with metastatic

Roche inks marketing pact with Elder  -  Dec 15, 2006
Business Standard,The Ibandronate tablet, priced above Rs 1 lakh in India, is one of the latest introductions by Roche in the bisphophonate segment.

Doctor: Osteoporosis should be a concern for women who smoke ...  -  Dec 7, 2006
49abcnews.com,Currently, bisphosphonates -- alendronate, ibandronate and risedronate -- calcitonin, estrogens, parathyroid hormone and raloxifene are approved by the US

Jawbone death risk small from medications  -  Dec 7, 2006
United Press International...take oral bisphosphonate drugs, a class of drugs that includes alendronate, or Fosamax; ibandronate, or Boniva; risedronate, or Actonel; and others.

Osteoporosis Meds And Jaw Pain: What's The Risk?  -  Dec 11, 2006
Medical News Today (press release),To treat osteoporosis, millions of Americans take oral bisphosphonate drugs, a class of drugs that includes alendronate (Fosamax), ibandronate (Boniva),

Phoenix II: JJ Yeley preview  Nov 8, 2006
JJ Yeley, driver of the No. 18 Boniva (ibandronate sodium) Chevrolet for Joe Gibbs Racing, might have an idea of how Dorothy felt. ... -Motorsport.com, What's going around Collier County  Oct 25, 2006
The treatment for osteoporosis in men is the same as for women: alendronate, risendronate or ibandronate, along with calcium and vitamin D. If calcium intake ... -WBBH, Cyclacel Pharmaceuticals Names John Womelsdorf, Ph.D., Vice ...  Oct 24, 2006
...and negotiating Roche's only global co-development/co-promotion agreement in a transaction with GlaxoSmithKline to commercialize ibandronate in osteoporosis. ... -PharmaLive.com (press release), Women More Likely to Stay on Once-Monthly Ibandronate Versus Once ...  Sep 18, 2006
18, 2006 -- According to six-month results of ongoing studies, women with postmenopausal osteoporosis taking once-monthly Boniva(R) (ibandronate sodium) were ... -DG News

Roche: Positive Study On Osteoporosis Drug Bonviva  Sep 18, 2006
BASEL -(Dow Jones)- Swiss pharmaceutical company Roche Holding AG (RHHBY) Tuesday released a positive study on its osteoporosis drug ibandronate, or Bonviva. ... -Easy Bourse (Communiqués de presse)

Higher Persistency Rates Seen with FOSAMAX(R) Once Weekly ...  Sep 19, 2006
...rates were seen among osteoporosis patients taking FOSAMAX(R) Once Weekly (alendronate) therapies than were seen among patients taking ibandronate once monthly ... -Business Wire

Market Report -- In Play (MRK)  Sep 19, 2006
...rates were seen among osteoporosis patients taking Fosamax Once Weekly (alendronate) therapies than were seen among patients taking ibandronate once monthly or ... -MSN Money

Health — Pharmacy Q&A  Sep 13, 2006
...bisphosphonates. Others include Fosamax (alendronate), Boniva (ibandronate), Skelid (Tiludronate), and Didronel (etidronate). Aredia ... -The Stamford Times

Boniva advertising 'not misleading' says US judge  Sep 8, 2006
Sanofi-Aventis and P&G's pharmaceuticals division had objected to DTC advertising for Boniva (ibandronate sodium), a bisphosphonate drug used to increase bone ... -Pharma Times (subscription)

Roche and GSK Win Key Ruling in US District Court on Boniva ...  Sep 8, 2006
...a move by their competitors to limit marketing activities in support of the once-monthly medicine for postmenopausal osteoporosis, Boniva® (ibandronate sodium ... -PharmaLive.com

Doctor: Osteoporosis should be a concern for women who smoke ...  -  Dec 7, 2006
49abcnews.com,Currently, bisphosphonates -- alendronate, ibandronate and risedronate -- calcitonin, estrogens, parathyroid hormone and raloxifene are approved by the US

Jawbone death risk small from medications  -  Dec 7, 2006
United Press International...take oral bisphosphonate drugs, a class of drugs that includes alendronate, or Fosamax; ibandronate, or Boniva; risedronate, or Actonel; and others.

Phoenix II: JJ Yeley race report  -  Nov 13, 2006
Motorsport.com,18 Boniva® (ibandronate sodium) Chevrolet for Joe Gibbs Racing, churned out another gritty performance, fighting back to finish 20th in front of his

Osteoporosis Meds And Jaw Pain: What's The Risk?  -  Dec 11, 2006
Medical News Today (press release),To treat osteoporosis, millions of Americans take oral bisphosphonate drugs, a class of drugs that includes alendronate (Fosamax), ibandronate (Boniva),

JJ Yeley Post-Race Notes: Checker Auto Parts 500  -  Nov 13, 2006
WhoWon.com,After restarting 22nd on lap 230 , Yeley brought his Boniva® (ibandronate sodium) Chevrolet through the field and moved up to 18th by lap 271.

NASCAR: JOE GIBBS RACING race report - Phoenix  -  Nov 13, 2006
noticias.info (press release),18 Boniva® (ibandronate sodium) Chevrolet, finished 20th to secure his third straight top-20 finish. Hamlin continues to lead the trio of JGR drivers in the

COMBINING BISPHOSPHONATES WITH RALOXIFENE TO TREAT OSTEOPOROSIS: A ...  Aug 21, 2006
A MEDLINE search (1966–February 2006) was conducted using the search terms osteoporosis, alendronate, risedronate, ibandronate, raloxifene, bisphosphonate ... -The Journal of Pharmacy Technology

Bonviva Effective as a Once-Monthly Oral Formulation for ...  Jul 31, 2006
Ibandronate (ibandronic acid) once monthly (Bonviva 150mg) received a positive opinion on granting a marketing authorisation from the European Medicines ... -Business Portal 24

Prevention and Management of Bisphosphonate Toxicities Reviewed  Aug 15, 2006
...estimate that 2% of patients have serious complications after receiving intravenous Zometa® (zoledronic acid, Aredia® (pamidronate) or Boniva® (ibandronate ... -Cancer Consultants

Actress and Osteoporosis Advocate Sally Field Salutes Women's ...  Aug 2, 2006
At that time, Field began an active osteoporosis management program and treats her condition with once-monthly Boniva(R) (ibandronate sodium), a prescription ... -PR Newswire

Monthly tablets help women persist longer with osteoporosis drugs  22 Jul 2006
...a single 70mg dose of alendronate (marketed by Merck as Fosamax) once a week and the remainder received a single monthly 150mg dose of ibandronate (marketed as ... -Pharmaceutical Business Review



Self-tanning creams spark rashes, itching  16 May 2006
...immediately. Your osteoporosis drug Actonel (risedronate) is in the same category as Fosamax (alendronate) and Boniva (ibandronate). ... - Charlotte Observer

Two-Year MOBILE Analysis of Ibandronate Validates Lumbar Spine and ...  May 2, 2006
CHICAGO, IL -- May 2, 2006 -- A 2-year analysis of oral ibandronate for the treatment of postmenopausal osteoporosis shows that the treatment reduced markers ... - DG News

Intravenous Form and Labeling Approved for Ibandronate: Presented ...  May 1, 2006
...marrow density (BMD) as a proxy end-point for efficacy in reducing fractures among postmenopausal women, a study of intravenous (IV) ibandronate injections won ... - DG News

Intravenous Ibandronate May Be Associated With Higher Incidence of ...  May 1, 2006
CHICAGO, IL -- May 1, 2006 -- While use of intravenous (IV) ibandronate may lead to a greater likelihood of developing an influenza-like illness, as well as ... - DG News

Rookie JJ Yeley to Drive Boniva Car on Mother's Day Weekend  May 8, 2006
The sponsorship aims to help raise awareness about postmenopausal osteoporosis and once-monthly Boniva® (ibandronate sodium) tablets. ... - Auto Racing Daily

Sally Field's New Cause: Strong Bones  May 10, 2006
Roche and GlaxosmithKline, makers of the drug Boniva (ibandronate sodium), are sponsoring Field's outreach and educational campaign. ... - Hartford Courant

Don't be dense -- osteoporosis can affect everyone -- even you  May 3, 2006
Ibandronate (boniva) is the first monthly pill available to treat any chronic disease. It is also given every three months intravenously. ... - Petaluma Argus-Courier

Medical Files : Getting over the ‘hump’  Apr 28, 2006
Currently, bisphosphonates such as ibandronate (Bonviva), calcitonin, estrogens and parathyroid hormone are approved by the US Food and Drug Administration for ... - INQ7.net

Sally Field Brings Osteoporosis to Center Stage  Apr 21, 2006
Bone Health" campaign. The two companies are the co-marketers of Boniva (ibandronate sodium), an osteoporosis medication. Through a ... - Forbes

Baby Boom Icon Sally Field Takes on New Leading Role As Women's ...  Apr 20, 2006
Her doctor then recommended that she begin taking medicine, and he prescribed Boniva(R) (ibandronate sodium), a once-monthly tablet for postmenopausal ... - PharmaLive.com





Oral Ibandronate and IV May Be Equally Efficacious in Treating ...  Mar 27, 2006
NICE, FRANCE -- March 27, 2006 -- Patients with metastatic bone disease due to breast cancer may respond equally well to oral ibandronate (Boniva) as they do ... - DG News

Roche Says EU Approves Bonviva (Ibandronate) as Quarterly ...  Mar 31, 2006
Friday said they have received the European marketing authorization for the quarterly intravenous injection of the osteoporosis medication Bonviva (ibandronate ... - DG News

International Approvals: Lyrica and Bonviva  Apr 3, 2006
...a new indication for pregabalin, allowing its use in the treatment of generalized anxiety disorder, and an injectable formulation of ibandronate sodium for ... - Medscape (subscription)

Women With Osteoporosis Prefer One Tablet Per Month, Study Shows  Mar 18, 2006
1. Hadji P, Benhamou CL, Devas V, Masanauskaite D, Barrett-Connor E. Women With Postmenopausal Osteoporosis Prefer Once-Monthly Oral Ibandronate to Weekly Oral ... - Medical News Today

New Bonviva Quarterly Injection Approved in Europe for ...  Mar 31, 2006
DIVA compares the safety, efficacy and tolerability of the once-daily oral ibandronate 2.5mg regimen with two novel IV regimes: 2mg every two months and 3mg ... - PharmaLive.com

New Data Support Bondronat's Superior Renal Safety Profile Against ...  Mar 24, 2006
Comparison of renal impairment in multiple myeloma patients treated with zoledronic acid or ibandronate: a retrospective review. ... - DG News

Roche says EU approves Bonviva as quarterly treatment  Mar 31, 2006
Previous studies have shown that once-daily oral ibandronate reduced the risk of vertebral fracture in women with postmenopausal osteoporosis by 62% when taken ... - MarketWatch

Forecasts Tell Us That Bisphosphonates Will Remain the Mainstay of ...  Mar 27, 2006
...with 6.9% annual sales growth through our study period, driven by the emergence of two new agents: Roche/GlaxoSmithKline's ibandronate (Boniva/Bonviva) and ... - Genetic Engineering News

Innovative osteoporosis treatment, FOSAVANCE(TM), integrates two ...  Mar 28, 2006
...and second generation bisphosphonates and other commonly used anti-osteoporosis treatments through January 2005 (etidronate, ibandronate, miacalcin, pamidronate ... - Canada NewsWire

Lead May Be the Bullet Causing Osteoporosis in Senior Citizens  Mar 27, 2006
The FDA has approved Boniva (ibandronate sodium) Injection as the first intravenous medication for the treatment of postmenopausal osteoporosis, Roche and ... - SeniorJournal.com

New Study Shows Women With Osteoporosis Preferred Once-Monthly ...  Mar 17, 2006
...two-thirds (70%) of women with postmenopausal osteoporosis, who expressed a preference, preferred once-monthly dosing with Boniva(R) (ibandronate sodium) over ... - DG News

Double boost for Bonviva in osteoporosis  Mar 20, 2006
Roche and GSK will see BALTO II results as a plus for Bonviva (ibandronate) - currently the only once-monthly oral treatment for osteoporosis - especially as ... - Pharma Times (subscription)



Bisphosphonate Safety Evaluation Shows General Safety: Presented ...  Feb 21, 2006
VIENNA, AUSTRIA -- February 21, 2006 -- While oral ibandronate (Bondronat(R)) provides decreased incidence of skeletal-related effects, rapid and sustained ... - DG News

Older Men Surviving Heart Attack at Higher Risk of Osteoporosis  Feb 21, 2006
The FDA has approved Boniva (ibandronate sodium) Injection as the first intravenous medication for the treatment of postmenopausal osteoporosis. Read more... ... - SeniorJournal.com,

Scots get new drug to fight against bone disease  Feb 13, 2006
Bonviva, also known as ibandronate, was approved for post-menopausal women with osteoporosis for use across the NHS by the Scottish Medicines Consortium. ... - Scotsman,

Scottish Medicines Consortium Approves Bonviva® - Scottish Women ...  Feb 14, 2006
Several thousand women across Scotland will now have access to a new drug called Bonviva® (ibandronic acid also known as ibandronate), following its approval ... - Medical News Today,

FDA Approves First IV Treatment for Postmenopausal Osteoporosis ...  Jan 9, 2006
NUTLEY, NJ, and RESEARCH TRIANGLE PARK, NC -- January 9, 2006 -- The US Food and Drug Administration (FDA) has approved Boniva(R) (ibandronate sodium) Injection ... - DG News

European positive opinion for first quarterly IV injection for  Jan 27, 2006
DIVA compares the safety, efficacy and tolerability of the approved once-daily oral ibandronate 2.5mg regimen with two novel IV regimes: 2mg every two months ... - WebWire

FDA approves first quarterly IV injection for postmenopausal ...  Jan 9, 2006
Gorana Dasic, the US Ibandronate Medical Director at GSK said: "Boniva Injection is the first IV bisphosphonate to be approved for osteoporosis treatment ... - Biotech Intelligence

It is Predicted in the Next Ten Years the Demand for Drugs to ...  Feb 3, 2006
...with 6.9% annual sales growth through our study period, driven by the emergence of two new agents: Roche/GlaxoSmithKline's ibandronate (Boniva/Bonviva) and ... - International News Service

Boniva for injection cleared in USA  Jan 9, 2006
Boniva for injection (ibandronate sodium), developed by GlaxoSmithKline and Roche, is aimed at people who find it hard to adhere to treatment with the current ... - Pharma Times (subscription)

Osteoporosis Information Now Online at NIHSeniorHealth  Jan 27, 2006
The FDA has approved Boniva (ibandronate sodium) Injection as the first intravenous medication for the treatment of postmenopausal osteoporosis, Roche and ... - SeniorJournal.com

FDA Approves First IV Treatment for Postmenopausal Osteoporosis ...  Jan 6, 2006
6 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved Boniva(R) (ibandronate sodium) Injection, the first intravenous (IV) medication for ... - PR Newswire

Companies say FDA approves IV version of postmenopausal ...  Jan 9, 2006
Boniva Injection, formally known as ibandronate sodium, becomes the first intravenous drug for the treatment of postmenopausal osteoporosis, Roche and ... - Redlands Daily Facts

Business Briefing  Jan 7, 2006
Boniva Injection, formally known as ibandronate sodium, becomes the first intravenous drug for the treatment of postmenopausal osteoporosis, Roche and ... - The Ledger


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional